2853
Eosin B Solution
0.1% aqueous solution
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
| Pack Size | SKU | Availability | Price |
|---|
About This Item
Pricing and availability is not currently available.
Quality Level
form
solution
IVD
for in vitro diagnostic use
concentration
0.1%
application(s)
hematology
histology
storage temp.
room temp
SMILES string
[Na+].[Na+].[O-]C(=O)c1ccccc1C2=C3C=C(C(=O)C(Br)=C3Oc4c(Br)c([O-])c(cc24)[N+]([O-])=O)[N+]([O-])=O
InChI
1S/C20H8Br2N2O9.2Na/c21-14-16(25)11(23(29)30)5-9-13(7-3-1-2-4-8(7)20(27)28)10-6-12(24(31)32)17(26)15(22)19(10)33-18(9)14;;/h1-6,25H,(H,27,28);;/q;2*+1/p-2
InChI key
GYYTYUGGVBYJHE-UHFFFAOYSA-L
Application
Used as a counterstain in Sigma Procedure 285 for Fetal Hemoglobin.
Other Notes
Eosin B, 0.1%, aqueous solution. Sodium azide, 0.1% added as preservative
Storage Class
12 - Non Combustible Liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Nilay S Sethi et al.
Nature genetics, 52(2), 219-230 (2020-02-07)
Somatic alterations in cancer genes are being detected in normal and premalignant tissue, thus placing greater emphasis on gene-environment interactions that enable disease phenotypes. By combining early genetic alterations with disease-relevant exposures, we developed an integrative mouse model to study
Lucía Margarita Valenzuela-Salas et al.
Pharmaceutics, 13(1) (2021-01-13)
Nanomaterials quickly evolve to produce safe and effective biomedical alternatives, mainly silver nanoparticles (AgNPs). The AgNPs' antibacterial, antiviral, and antitumor properties convert them into a recurrent scaffold to produce new treatment options. This work reported the full characterization of a
Rocky Strollo et al.
Diabetologia, 58(12), 2851-2860 (2015-09-10)
Insulin is the most specific beta cell antigen and a potential primary autoantigen in type 1 diabetes. Insulin autoantibodies (IAAs) are the earliest marker of beta cell autoimmunity; however, only slightly more than 50% of children and even fewer adults